LZI MULTIPLE ANALYTE SET A;B;C DRUGS OF ABUSE CONTROLS— 510(k) K133710
Substantially EquivalentLin-Zhi International, Inc.
FDA 510(k) clearance K133710 for LZI MULTIPLE ANALYTE SET A;B;C DRUGS OF ABUSE CONTROLS, Substantially Equivalent on 2014-02-21. Applicant: Lin-Zhi International, Inc..
Clearance details
- Applicant
- Lin-Zhi International, Inc.
- Product code
- Code DKB
- Advisory panel
- Clinical Toxicology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Sunnyvale, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.